Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
Text Size
1 study found for:    "mannose-binding lectin deficiency"

Modify this search | How to Use Search Results

Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Cancel
Rank Status Study
1 Withdrawn Recombinant Human Mannose-Binding Lectin (MBL) in Treating Young Patients With MBL Deficiency and Fever and Neutropenia
Conditions: Fever, Sweats, and Hot Flashes;   Infection;   Leukemia;   Lymphoma;   Myelodysplastic Syndromes;   Neutropenia;   Unspecified Childhood Solid Tumor, Protocol Specific
Intervention: Biological: recombinant human mannose-binding lectin
To Top

† Indicates status has not been verified in more than two years